N6-methyladenine Demethylase ALKBH1 Inhibits the Differentiation of Skeletal Muscle.

Li-Ting Diao,Shu-Juan Xie,Pei-Jie Yu,Yu-Jia Sun,Fan Yang,Ye-Ya Tan,Shuang Tao,Ya-Rui Hou,Ling-Ling Zheng,Zhen-Dong Xiao,Qi Zhang
DOI: https://doi.org/10.1016/j.yexcr.2021.112492
IF: 4.145
2021-01-01
Experimental Cell Research
Abstract:DNA N-6-methyladenine (N6-mA) was recently recognized as a new epigenetic modification in mammalian genome, and ALKBH1 was discovered as its demethylase. Knock-out mice studies revealed that ALKBH1 was indispensable for normal embryonic development. However, the function of ALKBH1 in myogenesis is largely unknown. In this study, we found that N6-mA showed a steady increase, going along with a strong decrease of ALKBH1 during skeletal muscle development. Our results also showed that ALKBH1 enhanced proliferation and inhibited differentiation of C2C12 cells. Genome-wide transcriptome analysis and reporter assays further revealed that ALKBH1 accomplished the differentiation inhibiting function by regulating a core set of genes and multiple signaling pathways, including increasing chemokine (C-X-C motif) ligand 14 (CXCL14) and activating ERK signaling. Taken together, our results demonstrated that ALKBH1 is critical for the myogenic differentiation of C2C12 cells, and suggested that N6-mA might be a new epigenetic mechanism for the regulation of myogenesis.
What problem does this paper attempt to address?